FDA Inspection 971832 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on March 25, 2016 in Tallahassee, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 25, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Tallahassee, FL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12321 | 21 CFR 1271.160(b)(3) | Problem description, disposition, date et. al. |